TR200200520T2 - Farmasötik preparat - Google Patents

Farmasötik preparat

Info

Publication number
TR200200520T2
TR200200520T2 TR2002/00520T TR200200520T TR200200520T2 TR 200200520 T2 TR200200520 T2 TR 200200520T2 TR 2002/00520 T TR2002/00520 T TR 2002/00520T TR 200200520 T TR200200520 T TR 200200520T TR 200200520 T2 TR200200520 T2 TR 200200520T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical preparation
preparation
cytosan
nanosol
bound
Prior art date
Application number
TR2002/00520T
Other languages
English (en)
Inventor
Hoffmann Hans-Rainer
Asmussen Bodo
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200200520T2 publication Critical patent/TR200200520T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • B01J13/0039—Post treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bulus, nanosol formunda en azindan bir adet kismen yüklü etken madde ihtiva eden ve bu etken maddenin zit yüklü bir citosan türevine bagli oldugu kati farmasötik preparat, bu preparatin imali ve tibbi amaçli ürünlerin hazirlanmasindaki kullanimi ile ilgilidir.
TR2002/00520T 1999-08-27 2000-08-14 Farmasötik preparat TR200200520T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19940794A DE19940794A1 (de) 1999-08-27 1999-08-27 Pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
TR200200520T2 true TR200200520T2 (tr) 2002-06-21

Family

ID=7919871

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00520T TR200200520T2 (tr) 1999-08-27 2000-08-14 Farmasötik preparat

Country Status (25)

Country Link
EP (1) EP1206253B1 (tr)
JP (1) JP2003508423A (tr)
KR (1) KR100624499B1 (tr)
CN (1) CN1181815C (tr)
AR (1) AR025392A1 (tr)
AT (1) ATE279180T1 (tr)
AU (1) AU779692B2 (tr)
BR (1) BR0013563A (tr)
CA (1) CA2382359C (tr)
CZ (1) CZ301704B6 (tr)
DE (2) DE19940794A1 (tr)
DK (1) DK1206253T3 (tr)
ES (1) ES2231265T3 (tr)
HK (1) HK1047037B (tr)
HU (1) HU227609B1 (tr)
IL (2) IL148220A0 (tr)
MX (1) MXPA02002048A (tr)
NZ (1) NZ517541A (tr)
PL (1) PL203860B1 (tr)
PT (1) PT1206253E (tr)
RU (1) RU2256440C2 (tr)
TR (1) TR200200520T2 (tr)
TW (1) TWI267384B (tr)
WO (1) WO2001015669A1 (tr)
ZA (1) ZA200201135B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
KR100767336B1 (ko) * 2006-04-19 2007-10-18 서평원 키틴/키토산계 기능성 유무기 복합물질 및 그 제조방법, 및그러한 복합물질의 용도
US9161901B2 (en) 2008-02-21 2015-10-20 University Of South Florida Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
DE102009024542A1 (de) * 2009-06-10 2010-12-16 Arivine Pharma Ag Zusammensetzungen auf Basis von Chitosan-Oligosacchariden

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474989A (en) * 1988-11-11 1995-12-12 Kurita Water Industries, Ltd. Drug composition
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
DE4140195C2 (de) * 1991-12-05 1994-10-27 Alfatec Pharma Gmbh Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung
RU2085187C1 (ru) * 1995-11-22 1997-07-27 Исследовательская корпорация МДТ Гель для ухода за кожей и лечения ее заболеваний и композиция для его получения
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
WO1997047323A2 (en) * 1996-06-11 1997-12-18 Zonagen, Inc. Chitosan drug delivery system
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
DE19845246A1 (de) * 1997-12-18 1999-06-24 Henkel Kgaa Vitaminhaltige Zubereitungen
DE69921773D1 (de) * 1998-01-16 2004-12-16 Univ Johns Hopkins Orale verabreichung von nukleinsäure-impstoffen durch partikelkomplexe

Also Published As

Publication number Publication date
JP2003508423A (ja) 2003-03-04
DK1206253T3 (da) 2005-01-31
BR0013563A (pt) 2002-07-09
HUP0300345A3 (en) 2009-01-28
EP1206253A1 (de) 2002-05-22
HK1047037A1 (en) 2003-02-07
PL354572A1 (en) 2004-01-26
WO2001015669A1 (de) 2001-03-08
ZA200201135B (en) 2002-08-28
ES2231265T3 (es) 2005-05-16
CN1181815C (zh) 2004-12-29
IL148220A0 (en) 2002-09-12
EP1206253B1 (de) 2004-10-13
PL203860B1 (pl) 2009-11-30
ATE279180T1 (de) 2004-10-15
NZ517541A (en) 2002-08-28
KR20020031416A (ko) 2002-05-01
AU7509400A (en) 2001-03-26
CN1370065A (zh) 2002-09-18
HUP0300345A2 (hu) 2003-09-29
CZ2002653A3 (cs) 2002-05-15
MXPA02002048A (es) 2002-08-20
RU2256440C2 (ru) 2005-07-20
TWI267384B (en) 2006-12-01
CA2382359C (en) 2008-03-18
CA2382359A1 (en) 2001-03-08
HU227609B1 (en) 2011-09-28
AR025392A1 (es) 2002-11-27
IL148220A (en) 2009-05-04
DE50008259D1 (de) 2004-11-18
KR100624499B1 (ko) 2006-09-18
DE19940794A1 (de) 2001-03-01
AU779692B2 (en) 2005-02-03
CZ301704B6 (cs) 2010-06-02
PT1206253E (pt) 2005-02-28
HK1047037B (zh) 2005-03-24

Similar Documents

Publication Publication Date Title
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
TR199802108T2 (tr) Ibandronat içeren oral farmasötik bir formülasyon.
TR200003788A2 (tr) Yavaş salımlı oral dozaj bileşim.
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
HUP0200248A3 (en) Oxamic acids and derivatives as thyroid receptor ligands, pharmaceutical compositions containing them as active ingredient and their use
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
MA24193A1 (fr) Procedes pour la preparation de conjugue peg-ifn alpha physiologiquement actif, et pour la preparation de compositions pharmaceutiques le contenant et leur utilisation
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
ATE267613T1 (de) Arzneimittel und deren verwendung
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
TR200200966T1 (tr) Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
FR2752732B1 (fr) Forme galenique a liberation prolongee de milnacipran
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
DE69812949D1 (de) Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
RU2002123182A (ru) Содержащая ибупрофен композиция
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
TR200200520T2 (tr) Farmasötik preparat
BR9809268A (pt) Unidade de dosagem farmacêutica, processo para fabricação da mesma, e, uso de um produto de amido como um veìculo para unidades de dosagem farmacêutica compreendendo tibolona
TR200003768T2 (tr) Hiperkalsemik krizler için terapötik aktif madde.
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı